Retatrutide 20mg
Retatrutide 20mg – Premium Research Peptide
Retatrutide is a next-generation tri-agonist peptide that activates GLP-1, GIP, and glucagon receptors. This triple-action mechanism has attracted strong research interest for its combined effects on appetite suppression, energy expenditure, and glucose control. Each vial contains 20mg of high-purity Retatrutide, making it a reliable choice for metabolic and endocrine research.
Key Benefits for Research
- High-purity 20mg vial of Retatrutide for extended studies
- Triple-agonist activity on GLP-1, GIP, and glucagon receptors
- Studied for weight management, glucose regulation, and fat metabolism
- USA-manufactured with rigorous lab quality controls
About Retatrutide
Retatrutide is a peptide under investigation for its broad incretin and glucagon receptor activity. By mimicking and enhancing multiple natural pathways, it shows promise in research related to obesity, type 2 diabetes, and overall metabolic health. Its multi-pathway effects differentiate it from single- and dual-agonist peptides.
Why Choose Our Retatrutide 20mg?
Our Retatrutide 20mg is synthesized using advanced peptide production methods to ensure maximum purity, molecular stability, and reliability. Each vial undergoes strict testing for identity, strength, and composition, providing consistent results for cutting-edge metabolic research.
Usage & Storage
- For laboratory research use only
- Store at -20°C for long-term stability
- Reconstitute with sterile solution prior to use
Product Details
- CAS Number: 2381089-83-2
- Molecular Formula: C335H508N88O103
- Molecular Weight: ~7,500 g/mol
- Appearance: White lyophilized powder






